Background No study has gathered evidence from all randomized clinical trials (RCT s) with
anti‐inflammatory drugs measuring antidepressant effects including a detailed assessment …

Background: Recent studies suggest that anti-inflammatory medication may play a role in
the treatment of mood disorders. Aims: The purpose of this study was to determine the …

The effects of celecoxib on a broad spectrum of mood disorders and on inflammatory
parameters have not yet been comprehensively evaluated. The aim of this study was to …

Introduction: Postpartum depression is a common mental health problem that is associated
with maternal suffering. The aim of this double-blind clinical trial was to compare safety and …

Neuropsychiatric disorders, such as depression, bipolar disorder, schizophrenia, obsessive-
compulsive disorder, and neurodevelopmental disorders such as autism spectrum disorder …

Neuroinflammation is recognised as one of the potential mechanisms mediating the onset of
a broad range of psychiatric disorders and may contribute to nonresponsiveness to current …

Patients with the HIV infection are at high risk for developing depression. The aim of this
study was to investigate the safety and efficacy of antidepressant effects of minocycline on …

Since depression remains a major public health issue there is a constant need for new and
more efficient therapeutic strategies based on the mechanisms involved in the aetiology of …

BACKGROUND Anti-inflammation drugs were uncovered to be a potential therapy for
depression. Celecoxib as a selective COX2 inhibitor is also one anti-inflammation drugs …

Background: Abundant evidence suggests that inflammatory cytokines contribute to the
symptoms of major depressive disorder (MDD) by altering neurotransmission …